# NovaBridge (NBP) — News

NBP · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/nbp/news

## Recent headlines

- [Polish central banker Dabrowski says global conflicts pose main risk to Polish inflation outlook](https://www.ainvest.com/news/polish-central-banker-dabrowski-global-conflicts-pose-main-risk-polish-inflation-outlook-2610) — AInvest Wire, Oct 14, 2026
  Polish central banker Tomasz Dabrowski has highlighted that global conflicts are the primary risk to Poland’s inflation outlook, according to recent statements. Dabrowski emphasized that ongoing geopolitical tensions, particularly the war in Ukraine, continue to exert upward pressure on inflation…
- [Novabridge Biosciences: Visara agreed to make additional aggregate payments of up to $104.0 mln based upon achievement of certain clinical development](https://www.ainvest.com/news/novabridge-biosciences-visara-agreed-additional-aggregate-payments-104-0-mln-based-achievement-clinical-development-2610) — AInvest Wire, Oct 13, 2026
  Novabridge Biosciences has entered into an agreement with Visara, stipulating additional aggregate payments of up to $104.0 million contingent upon the achievement of specific clinical development milestones. The terms of the agreement highlight the importance of key developmental benchmarks in the…
- [Novabridge Biosciences: Under terms of license agreement, Visara will pay Hiteck an upfront and near-term milestone payment of $7.0 million](https://www.ainvest.com/news/novabridge-biosciences-terms-license-agreement-visara-pay-hiteck-upfront-term-milestone-payment-7-0-million-2610) — AInvest Wire, Oct 13, 2026
- [Poland's Domanski sees rising pressure on rate hikes](https://www.ainvest.com/news/poland-domanski-sees-rising-pressure-rate-hikes-2610) — AInvest Wire, Oct 12, 2026
  Poland’s National Bank (NBP) has faced mounting pressure to raise interest rates further amid persistent inflationary pressures. As of 2025, Poland’s inflation rate stood at 3.81%, slightly above the NBP’s target range of 2.5% ± 1.0% . This figure marks a 0.6% increase from the previous year and…
- [Novabridge Biosciences announces expanded Givastomig safety and efficacy data to be presented at the European Society for Medical Oncology 2026](https://www.ainvest.com/news/novabridge-biosciences-announces-expanded-givastomig-safety-efficacy-data-presented-european-society-medical-oncology-2026-2610) — AInvest Wire, Oct 8, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).